Literature DB >> 34950354

Rate Control Versus Rhythm Control in Patients with Left Ventricular Assist Devices and Atrial Fibrillation.

Jasen L Gilge1, Asim Ahmed1, Bradley A Clark1, Kathleen Morris1, Zubin Yavar1, Nicolas Beaudrie1, Cameron Whitler1, Mahera Husain1, Mathew S Padanilam1, Parin J Patel1, Eric N Prystowsky1, Ashwinn K Ravichandra1.   

Abstract

BACKGROUND: Atrial fibrillation (AF) is a common comorbidity in patients with left ventricular assist devices (LVAD) with no defined guideline treatment strategy of rate versus rhythm control. The purpose of this study is to determine the effects of rate versus rhythm control for AF on the outcomes of patients with LVAD at our institution.
METHODS: Consecutive patients who underwent LVAD implantation at St Vincent Hospital from January 1, 2015 to December 31, 2017 were retrospectively evaluated. Patients with AF were identified and divided into rate control or rhythm control groups. The primary outcome evaluated was a composite of death, heart failure admission, gastrointestinal bleed, ventricular tachycardia, cerebrovascular accident, hemolysis, and pump thrombosis. Secondary outcomes included the individual variables from the primary outcome.
RESULTS: Out of 201 patients that underwent LVAD implantation, 81 had AF after implantation and were included with a median follow-up period of 384 days. The rate control group (n = 31; 38%) and the rhythm control group (n = 51; 62%) had no difference in composite outcomes (61% vs 59%, p = 0.83). When taken individually there was no difference in outcomes between the two groups. Thirteen patients underwent electrical cardioversion and successful conversion to normal sinus rhythm occurred in 71% of cases with a 60% recurrence rate.
CONCLUSIONS: There was no difference in primary outcome between rate and rhythm control groups. These data suggest that maintenance of sinus rhythm may not be necessary in all patients with LVAD.

Entities:  

Keywords:  Atrial Fibrillation; LVAD; Rhythm Control

Year:  2021        PMID: 34950354      PMCID: PMC8691283          DOI: 10.4022/jafib.20200474

Source DB:  PubMed          Journal:  J Atr Fibrillation        ISSN: 1941-6911


  15 in total

1.  [Mid-term outcomes of coronary artery bypass surgery with left radial artery bypassed to right main coronary artery of severe stenosis].

Authors:  D X Liu; X J Chen; J Zhang; X Z Chen; G Luo; Y J Liu; Y Xia; R B Tian
Journal:  Zhonghua Yi Xue Za Zhi       Date:  2019-11-12

2.  Clinical impact of atrial fibrillation in patients with the HeartMate II left ventricular assist device.

Authors:  Alan D Enriquez; Brandon Calenda; Parul U Gandhi; Ajith P Nair; Anelechi C Anyanwu; Sean P Pinney
Journal:  J Am Coll Cardiol       Date:  2014-10-27       Impact factor: 24.094

3.  Prognostic value of the presence and development of atrial fibrillation in patients with advanced chronic heart failure.

Authors:  H J Crijns; G Tjeerdsma; P J de Kam; F Boomsma; I C van Gelder; M P van den Berg; D J van Veldhuisen
Journal:  Eur Heart J       Date:  2000-08       Impact factor: 29.983

4.  Transthoracic cardioversion of atrial fibrillation: comparison of rectilinear biphasic versus damped sine wave monophasic shocks.

Authors:  S Mittal; S Ayati; K M Stein; D Schwartzman; D Cavlovich; P J Tchou; S M Markowitz; D J Slotwiner; M A Scheiner; B B Lerman
Journal:  Circulation       Date:  2000-03-21       Impact factor: 29.690

5.  Atrial Tachyarrhythmias Among Patients With Left Ventricular Assist Devices: Prevalence, Clinical Outcomes, and Impact of Rhythm Control Strategies.

Authors:  Andrew E Noll; Joseph Adewumi; Ram Amuthan; Carl B Gillombardo; Zariyat Mannan; Erich L Kiehl; Ayman A Hussein; Mina K Chung; Oussama M Wazni; Randall C Starling; Edward G Soltesz; Daniel J Cantillon
Journal:  JACC Clin Electrophysiol       Date:  2019-01-30

6.  Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study.

Authors:  Thomas J Wang; Martin G Larson; Daniel Levy; Ramachandran S Vasan; Eric P Leip; Philip A Wolf; Ralph B D'Agostino; Joanne M Murabito; William B Kannel; Emelia J Benjamin
Journal:  Circulation       Date:  2003-05-27       Impact factor: 29.690

7.  Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study.

Authors:  Sumeet S Chugh; Rasmus Havmoeller; Kumar Narayanan; David Singh; Michiel Rienstra; Emelia J Benjamin; Richard F Gillum; Young-Hoon Kim; John H McAnulty; Zhi-Jie Zheng; Mohammad H Forouzanfar; Mohsen Naghavi; George A Mensah; Majid Ezzati; Christopher J L Murray
Journal:  Circulation       Date:  2013-12-17       Impact factor: 29.690

8.  Biphasic versus monophasic shock waveform for conversion of atrial fibrillation: the results of an international randomized, double-blind multicenter trial.

Authors:  Richard L Page; Richard E Kerber; James K Russell; Tom Trouton; Johan Waktare; Donna Gallik; Jeff E Olgin; Philippe Ricard; Gavin W Dalzell; Ramakota Reddy; Ralph Lazzara; Kerry Lee; Mark Carlson; Blair Halperin; Gust H Bardy
Journal:  J Am Coll Cardiol       Date:  2002-06-19       Impact factor: 24.094

9.  Preoperative atrial fibrillation increases risk of thromboembolic events after left ventricular assist device implantation.

Authors:  John M Stulak; Salil Deo; John Schirger; Keith D Aaronson; Soon J Park; Lyle D Joyce; Richard C Daly; Francis D Pagani
Journal:  Ann Thorac Surg       Date:  2013-09-12       Impact factor: 4.330

10.  A meta-analysis of the prognostic significance of atrial fibrillation in chronic heart failure.

Authors:  Mamas A Mamas; Jane C Caldwell; Sanoj Chacko; Clifford J Garratt; Farzin Fath-Ordoubadi; Ludwig Neyses
Journal:  Eur J Heart Fail       Date:  2009-07       Impact factor: 15.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.